美国药业公司将以1600亿卢比收购健康营养公司85%, 扩大到消费者医疗保健领域. USV Pharma to buy 85% of Wellbeing Nutrition for ₹1,600 crore, expanding into consumer healthcare.

美国药业公司将收购位于孟买的健康和健康品牌Wellbeing Nutrition的85%股权, 交易价值为1,600亿卢比, 标志着消费者医疗保健的重大举措. USV Pharma is set to acquire an 85% stake in Mumbai-based Wellbeing Nutrition, a health and wellness brand, in a deal valued at ₹1,600 crore, marking a major move into consumer healthcare. 所有现金交易预计将在2026年3月结束, 创始人Avenish Chhabria在保留控制和领导权的同时, 卖出35%的股权, The all-cash transaction, expected to close by March 2026, sees founder Avnish Chhabria selling a 35% stake for around ₹800 crore while retaining control and leadership. 印度联合利华和Fireside Ventures在2022年投资后，以超过四倍的回报退出。 Hindustan Unilever and Fireside Ventures are exiting with over fourfold returns after investing in 2022. Wellbeing Nutrition成立于2019年，2025财年收入几乎增长三倍至11.9亿卢比，但仍处于亏损状态。 Wellbeing Nutrition, founded in 2019, has nearly tripled revenue to ₹119 crore in FY25 but remains loss-making. 由于国内市场迅速增长,购货符合美国维也纳办事处的战略,即从处方药扩大到消费营养。 The acquisition aligns with USV’s strategy to expand beyond prescription drugs into consumer nutrition, as the domestic market grows rapidly.